Saturday 31 October 2020
 
»
 
»
Story

Mohammed Alardhi

Investcorp launches China healthcare investment platform

MANAMA, September 14, 2020

Bahrain-based Investcorp, a leading global provider and manager of alternative investment products, said that it has launched a new platform dedicated to investing in high-quality Chinese healthcare companies.

As part of this initiative, Investcorp has acquired minority equity stakes in Lu Daopei Medical Group and WeDoctor. Terms of the transactions were not disclosed.

The new platform advances Investcorp’s Asia growth strategy and aims to create a highly curated portfolio of primary and secondary stakes in sector leading Chinese healthcare companies that have remained resilient through the pandemic and are expected to experience accelerated growth in the post-pandemic world.

Mohammed Alardhi, Executive Chairman of Investcorp, said: “Investcorp has been actively growing its presence in Asia as part of our strategy to provide our global clients with exposure to the strongest sectors and geographies around the world. The progress we have delivered on our expansion in Asia over the last two years, including establishing a world-class team and building our local expertise, has enabled us to take this significant next step in launching our first stand-alone investment platform in China. We believe that there are many attractive opportunities in the Chinese healthcare sector as this is a pivotal time to meet increasing demand for quality medical services and treatments.”

Hazem Ben-Gacem, Co-CEO of Investcorp, stated: “We are delighted to announce the launch of our new China healthcare platform and its maiden investments in LDP and WeDoctor. Both companies are recognized leaders in their respective fields, delivering strong market share growth through world-leading medical and digital technologies amidst recent market volatilities. We look forward to leveraging our resources and expertise in partnership with our portfolio companies to deliver exceptional care to patients and enhanced value for all of our stakeholders.”

Founded in 2001 by haematology expert Dr Lu Daopei, Lu Daopei Medical Group (LDP) has become the leading private specialist medical group in the field of haematology in China and a pioneer of bone marrow transplantation. LDP operates four hospitals across Beijing and Shanghai and is now the largest bone marrow transplant group for leukaemia treatment in the world.

WeDoctor is an online healthcare services company founded in 2010 by artificial intelligence expert Jerry Liao. The company has more than 240 million registered users for its online appointment booking, prescription and diagnosis services. The company builds, owns and operates one of China’s largest digital healthcare infrastructure platforms by linking hospitals and doctors with patients, pharmacies, insurance programs and financial services. – TradeArabia News Service
 




Tags:

More Finance & Capital Market Stories

calendarCalendar of Events

Ads